What dose of oral Primobolan do sources give?

Tablet strength and label dose
Label itemFigure
Tablet strength5 mg1
Usual adult dose10〜20 mg a day1
ScheduleSplit into 2–3 oral doses1

The Japanese label for Primobolan 5 mg tablets gives a usual adult dose of 10〜20 mg of metenolone acetate a day, split into 2–3 oral doses and adjusted by age and symptoms.1

Tablet strength and label dose

The table is set at the top of the page

The only label the searches found is Japanese (Bayer Yakuhin, revised August 2020), and it lists one product, Primobolan tablets 5 mg, as prescription-only.1 Searches of DailyMed and other sources found no US, EU or UK label for oral methenolone acetate. The label gives the packaging as 100 tablets, 10 to a PTP blister sheet, and states no stepping scheme beyond adjustment by age and symptoms.1

What trials and reports used

Human dosing detail for the oral tablet is thin: the trial and case-report summaries found give one weight-based trial dose and one case-report dose, the label's pharmacology section cites two oral doses in people, and none gives arm-by-arm tables.1

StudyDose and schedulePeopleLength
Kaltwasser 1988, randomised trialMethenolone 3 mg/kg by mouth with ATG 100 mg/kg, against ATG 100 mg/kg alone230 patients with aplastic anaemia, 15 per arm2Not stated in the summary2
Label pharmacology section (blood counts)Metenolone acetate 20 mg by mouth, daily1Healthy people and people with osteoporosis, hypogonadism or muscle disease; number not stated128日間1
Label pharmacology section (nitrogen retention)Metenolone acetate 20〜30 mg by mouth, daily, 330 mg in total1Healthy people and people with osteoporosis, hypogonadism or muscle disease; number not stated1Not stated1

Walker and colleagues' 1975 clinical trial of six anabolic steroids in men with ischaemic heart disease gives no methenolone acetate dose, group size or duration in its summary, which says methenolone acetate failed to enhance fibrinolysis.3

Tablet, not powder or liquid

The label gives the route as oral, and the active substance is practically insoluble in water.1 No liquid, topical or powder form turned up in the searches, and no mixing instructions or water volume exist in the sources saved. At 5 mg a tablet, the label's usual adult 10〜20 mg a day comes to two to four tablets a day; tablets are counted rather than drawn up, so no concentration or syringe mark applies.1

Storage

Once the outer box is unsealed, the label says to store the tablets protected from light.1 It states no temperature or time limit in the text saved, and nothing about storage after crushing or dissolving. The label's dispensing note tells pharmacists to advise taking tablets out of the PTP blister sheet before swallowing, since a swallowed sheet's hard, sharp edges can pierce the lining of the oesophagus.1

Frequently asked questions

Is oral Primobolan a controlled substance in the US?

The US federal Schedule III list names methenolone among anabolic steroids, including its salts, esters and ethers.4

What safety points does the label list?

The label lists androgen-dependent cancers such as prostate cancer, known or suspected, and women who are or may be pregnant, as contraindicated.1 It lists liver function disorder and jaundice as serious adverse reactions, frequency unknown.1

Was oral methenolone acetate given in a case report?

A 2024 case report by Ushimaru and colleagues, of a 73-year-old man with myelodysplastic syndrome and stage 4 chronic kidney disease, gives methenolone acetate 20 mg/day by mouth, with darbepoetin 480 μg/month subcutaneously.5 This is one patient, not a trial.5

References

  1. Bayer Yakuhin (JAPIC via KEGG MEDICUS). 医療用医薬品 : プリモボラン (プリモボラン錠5mg). kegg.jp
  2. PubMed. Effect of androgens on the response to antithymocyte globulin in patients with aplastic anaemia. 1988. pubmed.ncbi.nlm.nih.gov
  3. PubMed. Plasma fibrinolytic activity following oral anabolic steroid therapy. 1975. pubmed.ncbi.nlm.nih.gov
  4. eCFR. 21 CFR 1308.13 -- Schedule III. ecfr.gov
  5. PMC. Attenuation of Bone Mineral Density Decline During Anemia Treatment With Methenolone Acetate in Myelodysplastic Syndrome. 2024. pmc.ncbi.nlm.nih.gov